<DOC>
	<DOCNO>NCT00003467</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness carmustine treat adult recurrent supratentorial low-grade glioma .</brief_summary>
	<brief_title>Carmustine Treating Adults With Recurrent Supratentorial Low-Grade Glioma</brief_title>
	<detailed_description>OBJECTIVES : - Determine antitumor activity Gliadel wafer ( carmustine ) treatment recurrent supratentorial low grade glioma . - Assess toxicity therapy patient . OUTLINE : Patients stratify disease ( fibrillary astrocytoma v oligodendroglioma mixed glioma ) . Patients receive 8 Gliadel wafer ( contain carmustine ) implant resected tumor cavity . Patients follow every 2 month . PROJECTED ACCRUAL : This study accrue maximum 68 patient within 18-24 month .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm recurrent primary low grade glioma include : Fibrillary astrocytoma Oligodendroglioma Mixed glioma Evidence measurable enhance nonenhancing CNS neoplasm MRI PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : Hematocrit great 29 % Absolute neutrophil count great 1500/mm^3 Platelet count great 125,000/mm^3 Hepatic : SGOT le 1.5 time upper limit normal ( ULN ) Bilirubin le 1.5 time ULN Renal : Creatinine le 1.5 mg/dL BUN le 25 mg/dL Other : Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since prior chemotherapy unless disease progression Endocrine therapy : Concurrent corticosteroid allow ( must stable dose 1 week prior study ) No concurrent immunosuppressive agent Radiotherapy : At least 4 week since prior radiotherapy unless disease progression Surgery : Not specify Other : No concurrent medication may interfere study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult oligodendroglioma</keyword>
</DOC>